NEWS

2024/09/05

IR Library

1Q FY2024 update from OMEGA Investment [PDF：892KB]

2024/08/14

IR Library

[Presentation] Financial Results for 1Q FY 2024 [PDF：1388KB]

2024/08/14

IR Library

Summary of Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2025 [PDF：222KB]

2024/06/18

IR Library

Business alliance agreement for co-development of biosimilars [PDF：104KB]

2024/06/11

IR Library

Announcement of the Conclusion of an Outsourcing Agreement to Strengthen Collaboration with Biotech Ventures [PDF：131KB]

2024/05/30

IR Library

4Q FY2023 update from OMEGA Investment [PDF：818KB]

2024/05/14

IR Library

[Presentation] Financial Results for the FY 2023 [PDF：1786KB]

2024/05/14

IR Library

Summary of Financial Results for the Fiscal Year Ended March 31, 2024 (Non-consolidated) [PDF：212KB]

2024/03/25

IR Library

Announcement of revisions to FY2023 financial guidance [PDF：78KB]

2024/03/18

IR Library

Announcement of the loan arrangement from Japan Finance Corporation [PDF：74KB]

2024/03/11

IR Library

Announcement of manufacturing of SHED Master Cell Bank in compliance with US FDA Standards [PDF：98KB]

2024/03/08

IR Library

Notice of the Nomination of Candidates for Board Directors and Corporate Auditors [PDF：105KB]

2024/02/27

お知らせIR Library

3Q FY2023 update from OMEGA Investment [PDF：695KB]

2024/02/07

IR Library

[Presentation] Financial Results for 3Q FY 2023 [PDF：922KB]

2024/02/07

IR Library

Summary of Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2024
[PDF：363KB]

2024/01/12

IR Library

Announcement of establishment of a subsidiary in the cell therapy business (regenerative medicine) through a company split (simplified incorporation-type company split)  [PDF：230KB]

2023/12/21

IR Library

Announcement of the bank loan arrangement from Mizuho Bank, Ltd. for increased orders of GBS-007 [PDF：147KB]

2023/11/21

IR Library

Announcement of the launch of Pegfilgrastim biosimilar [PDF：149KB]

2023/11/14

IR Library

2Q FY2023 update from OMEGA Investment [PDF：759KB]

2023/11/13

IR Library

Announcement of research results at the 43^rd Annual Scientific Meeting of the Japanese Society of Ocular Pharmacology  -Optic neuroprotective effect with SHED- [PDF：126KB]

2023/11/08

IR Library

Summary of Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2024 [PDF：255KB]

2023/11/08

IR Library

[Presentation] Financial Results for 2Q FY 2023 [PDF：1089KB]

2023/10/16

IR Library

Announcement of enrollment of the first case of clinical research plan for children with cerebral palsy under the initiative of Nagoya University  [PDF：142KB]

2023/09/27

IR Library

Announcement of approval of additional indication of Ranibizumab BS [PDF：141KB]

2023/09/25

IR Library

Announcement of Receiving Manufacturing and Sales Approval for biosimilar in the Oncology in Japan [PDF：204KB]

2023/08/15

IR Library

1Q FY2023 update from OMEGA Investment[PDF：982KB]

2023/08/07

IR Library

Summary of Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2024[PDF：339KB]

2023/08/07

IR Library

[Presentation] Financial Results for 1Q FY 2023[PDF：1360KB]

2023/07/14

IR Library

Correction of the press release on July 10, 2023 [PDF：187KB]

2023/07/10

IR Library

Working Capital Financing for stable supply for GBS-007 (18th series of stock acquisition rights with exercise price adjustment clause) [PDF：206KB]

2023/07/10

IR Library

[Presentation] Working Capital Financing for Stable Supply of GBS-007 [PDF：686KB]

2023/06/29

IR Library

Appointment of new CEO  [PDF：156KB]

2023/06/06

IR Library

Announcement of organizational and personnel changes [PDF：196KB]

2023/06/06

IR Library

Announcement of partial changes in the Articles of Incorporation [PDF：143KB]

2023/06/06

IR Library

Announcement of appointment of New CEO and Board Directors [PDF：249KB]

2023/05/22

IR Library

Establishment of stable storage and transportation system of SHED [PDF：192KB]

2023/05/19

IR Library

Company note 4QFY2022 update from OMEGA Investment [PDF：1155KB]

2023/05/12

IR Library

[Presentation] Financial Results for the FY 2022 [PDF：1817KB]

2023/05/12

IR Library

Summary of Financial Results for the Fiscal Year Ended March 31, 2023 (Non-consolidated) [PDF：374KB]

2023/05/08

IR Library

Announcement of presentation on basic research results of SHED at American Society of Gene & Cell Therapy (ASGCT)[PDF：143KB]

2023/02/20

IR Library

The Company’s opinion on Glass Lewis’ voting recommendation on the agenda item to be proposed at the extraordinary general meeting of shareholders [PDF：152KB]

2023/02/20

IR Library

Update of clinical research plan of Nagoya University [PDF：144KB]

2023/02/13

IR Library

Company note 3Q FY2023/3 update from OMEGA Investment [PDF：800KB]

2023/02/10

IR Library

Update from Heartseed Inc.: Successful transplantation of the first case in the Phase I/II LAPiS study of HS-001, a myocardial regenerative therapy utilizing iPS cells [PDF：117KB]

2023/02/07

IR Library

[Presentation] Financial Results for the Third Quarter of FY2022 [PDF：1790KB]

2023/02/07

IR Library

Summary of Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2023
(Excerpt from Japanese version) [PDF：465KB]

2023/01/30

IR Library

Update of clinical research plan of Nagoya University [PDF：144KB]

2023/01/26

IR Library

ANALYST NET Company Report was released by Fair Research Inc.  [PDF：1372KB]

2023/01/13

IR Library

The Company’s opinion on shareholders’ proposal (Excerpt from Japanese version)
[PDF：191KB]

2023/01/13

IR Library

Announcement of approval of additional indication of Ranibizumab BS  (Excerpt from Japanese version) [PDF：206KB]

2022/04/04

IR Library

Announcement of execution of share transfer agreement of the consolidated subsidiary and share purchase agreement with Metcela Inc., and change in the purpose of the 10th share acquisition rights due to this transaction (Extracted from Japanese version)

[PDF：291KB]

2022/03/24

IR Library

2022/03/17

IRIR Library

2022/03/07

IRIR Library

Company note 3Q update from OMEGA Investment [PDF：523KB]

2022/02/04

IRIR Library

[Presentation] Financial Results for the Third Quarter of FY2021 [PDF：1670KB]

2022/02/04

IRIR Library

Summary of Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2022
[PDF：469KB]

2022/01/26

IR Library

Announcement of business alliance agreement with Metcela Inc. for the regenerative medicine business [PDF：207KB]

2021/12/09

お知らせIR Library

Announcement of the launch of Ranibizumab BS [PDF：120KB]

2021/11/25

お知らせIR Library

Company note 2Q update from OMEGA Investment [PDF：274KB]

2021/11/05

お知らせ決算短信IR Library

Summary of Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2021 [PDF：470KB]

2019/11/22

topics

2019/05/10

topics

Notice of Relocation of Head Office Function, Relocation of Tokyo Office, and Integration of Subsidiaries office [PDF：137KB]

2019/05/10

topics

Announcement of signing a joint research and development agreement with ORTHOREBIRTH for cleft lip/cleft palate [PDF：198KB]

2019/03/12

topics

Notice of Resolutions at the Extraordinary General Shareholders Meeting [PDF：297KB]

2019/02/28

topics

Completion of the enrollment of the final patient in the Phase III study for ophthalmologic biosimilar [PDF：78KB]

2019/02/05

topics

FY2018 3Q IR Meeting Information  [PDF：2408KB]

2019/01/31

topics

GTS and Senju sign a licensing agreement with Ocumension Therapeutics on biosimilar in ophthalmologic field [PDF：93KB]

2019/01/17

topics

[Presentation] Execution of Share Exchange Agreement and Conversion of Advanced Cell Technology and Engineering into Wholly-Owned Subsidiary of Kidswell Bio Corporation  [PDF：1833KB]

2019/01/17

topics

[Announcement] Execution of Share Exchange Agreement and Conversion of Advanced Cell Technology and Engineering into Wholly-Owned Subsidiary of Kidswell Bio Corporation [PDF：348KB]

2018/09/28

topics

Submission of New Drug Application in Japan of Darbepoetin alfa Biosimilar [PDF：169KB]